In vitro osteogenesis on a highly bioactive glass-ceramic (Biosilicate®)

Journal of Biomedical Materials Research - Part A

Volumn 82, Issue 3, 2007, Pages 545-557

  Moura, João ^a   Teixeira, Lucas Novaes ^a   Ravagnani, Christian ^b   Peitl, Oscar ^b   Zanotto, Edgar Dutra ^b   Beloti, Márcio Mateus ^a   Panzeri, Heitor ^a   Rosa, Adalberto Luiz ^a   De Oliveira, Paulo Tambasco ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

Author keywords

Bioactive glass; Bioactivity; Cell culture; Crystallization; Glass ceramic; Osteogenesis

Indexed keywords

BIOACTIVE GLASS; CELL CULTURE; CRYSTALLIZATION; FOURIER TRANSFORM INFRARED SPECTROSCOPY; SCANNING ELECTRON MICROSCOPY;

ENZYMATIC DIGESTION; IMPLANT DEVICES; OSTEOGENESIS;

GLASS CERAMICS;

BIOCERAMICS; GLASS;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CALVARIA; CELL PROLIFERATION; CERAMIC PROSTHESIS; CONTROLLED STUDY; CRYSTALLIZATION; CYTOSKELETON; IN VITRO STUDY; INFRARED SPECTROSCOPY; NEWBORN; NONHUMAN; OSTEOBLAST; RAT; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY;

ANIMALS; APATITES; BONE AND BONES; BONE SUBSTITUTES; CALCIFICATION, PHYSIOLOGIC; CELLS, CULTURED; CERAMICS; OSTEOGENESIS; RATS; SILICATES; STRESS FIBERS; SURFACE PROPERTIES;

EID: 34547858156     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.31165     Document Type: Article

References (50)

1. Hench LL, Wilson J. An introduction to bioceramics. Singapore:World Scientific; 1993. 386 pp.
2. Ducheyne P, Qiu Q. Bioactive ceramics: The effect of surface reactivity on bone formation and bone cell function. Biomaterials 1999;20:2287-2303.
3. Hench LL, Polak JM, Xynos ID, Buttery LDK. Bioactive materials to control cell cycle. Mat Res Innov 2000;3:313-323.
4. Xynos ID, Edgar AJ, Buttery LD, Hench LL, Polak JM. Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass 45S5 dissolution. J Biomed Mater Res 2001;55:151-157.
5. Hench LL, Polak JM. Third-generation biomedical materials. Science 2002;295:1014-1017.
6. Dieudonne SC, van den Dolder J, de Ruijter JE, Paldan H, Peltola T, van't Hof MA, Happonen RP, Jansen JA. Osteoblast differentiation of bone marrow stromal cells cultured on silica gel and sol-gel-derived titania. Biomaterials 2002;23:3041-3051.
7. James PF. Glass ceramics: New compositions and uses. J Non-Cryst Solids 1995;181:1-15.
8. Brömer H, Kaes HH, Pfeil E(to ERNST LEITZ GmbH). Biocompatible glass ceramic material. US Patent Documents No. 3,981,736, 21 Sep. 1976. Int. C. A61F001/00.
9. Kokubo T, Ito S, Shigematsu M, Yamamuro T. Mechanical properties of a new type of apatite-containing glass-ceramic for prosthetic application. J Mater Sci 1985;20:2001-2004.
10. Hench LL, West JK. Biological applications of bioactive glasses. Life Chem Rep 1996;13:187-241.
11. Peitl Filho O, LaTorre GP, Hench LL. Effect of crystallization on apatite-layer formation of bioactive glass 45S5. J Biomed Mater Res 1996;30:509-514.
12. 2 glass-ceramics. J Non-Cryst Solids 2001;292:115-126.
13. Chen QZ, Thompson ID, Boccaccini AR. 45S5 Bioglass((R))-derived glass-ceramic scaffolds for bone tissue engineering. Biomaterials 2006;27:2414-2425.
14. Zanotto ED, Ravagnani C, Peitl O, Panzeri H, Lara EH. Process and compositions for preparing particulate, bioactive or resorbable biosilicates for use in the treatment of oral ailments, WO2004/074199, Fundação Universidade Federal De São Carlos; Universidade De São Paulo, 20 Feb. 2004, Int. C. C03C10/00.
15. Kokubo T, Kushitani H, Sakka S, Kitsugi T, Yamamuro T. Solutions able to reproduce in vivo surface-structure changes in bioactive glass-ceramic A-W. J Biomed Mater Res 1990;24:721-734.
16. Kokubo T, Takadama H. How useful is SBF in predicting in vivo bone bioactivity? Biomaterials 2006;27:2907-2915.
17. Nanci A, Zalzal S, Gotoh Y, McKee MD. Ultrastructural characterization and immunolocalization of osteopontin in rat calvarial osteoblast primary cultures. Microsc Res Tech 1996;33:214-231.
18. Irie K, Zalzal S, Ozawa H, McKee MD, Nanci A. Morphological and immunocytochemical characterization of primary osteogenic cell cultures derived from fetal rat cranial tissue. Anat Rec 1998;252:554-567.
19. De Oliveira PT, Zalzal SF, Irie K, Nanci A. Early expression of bone matrix proteins in osteogenic cell cultures. J Histochem Cytochem 2003;51:633-641.
20. De Oliveira PT, Nanci A. Nanotexturing of titanium-based surfaces upregulates expression of bone sialoprotein and osteopontin by cultured osteogenic cells. Biomaterials 2004;25:403-413.
21. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
22. Majors AK, Boehm CA, Nitto H, Midura RJ, Muschler GF. Characterization of human bone marrow stromal cells with respect to osteoblastic differentiation. J Orthop Res 1997;15:546-557.
23. Conover WJ. Some methods based on ranks. In: Conover WJ, editor. Practical nonparametric statistics, 2nd ed. New York: Wiley; 1980. p 213-343.
24. Stoch L, Sroda M. Infrared spectroscopy in the investigation of oxide glasses structure. J Mol Struct 1999;511/512:77-84.
25. 2O). J Biomed Mater Res A 2003;66:110-119.
26. Xynos ID, Edgar AJ, Buttery LD, Hench LL, Polak JM. Ionic products of bioactive glass dissolution increase proliferation of human osteoblasts and induce insulin-like growth factor II mRNA expression and protein synthesis. Biochem Biophys Res Commun 2000;276:461-465.
27. Loty C, Sautier JM, Tan MT, Oboeuf M, Jallot E, Boulekbache H, Greenspan D, Forest N. Bioactive glass stimulates in vitro osteoblast differentiation and creates a favorable template for bone tissue formation. J Bone Miner Res 2001;16:231-239.
28. Rosengren A, Oscarsson S, Mazzocchi M, Krajewski A, Ravaglioli A. Protein adsorption onto two bioactive glass-ceramics. Biomaterials 2003;24:147-155.
29. Gough JE, Notingher I, Hench LL. Osteoblast attachment and mineralized nodule formation on rough and smooth 45S5 bioactive glass monoliths. J Biomed Mater Res A 2004;68:640-650.
30. Tosatti S, Schwartz Z, Campbell C, Cochran DL, Vande-Vondele S, Hubbell JA, Denzer A, Simpson J, Wieland M, Lohmann CH, Textor M, Boyan BD. RGD-containing peptide GCRGYGRGDSPG reduces enhancement of osteoblast differentiation by poly(1-lysine)-graft-poly(ethylene glycol)-coated titanium surfaces. J Biomed Mater Res A 2004;68:458-472.
31. Blystone SD. Integrating an integrin: A direct route to actin. Biochim Biophys Acta 2004;1692:47-54.
32. Schoenwaelder SM, Burridge K. Bidirectional signaling between the cytoskeleton and integrins. Curr Opin Cell Biol 1999;11:274-286.
33. Hynes RO. The dynamic dialogue between cells and matrices: Implications of fibronectin's elasticity. Proc Natl Acad Sci USA 1999;96:2588-2590.
34. Pompe T, Renner L, Werner C. Nanoscale features of fibronectin fibrillogenesis depend on protein-substrate interaction and cytoskeleton structure. Biophys J 2005;88:527-534.
35. Moursi AM, Damsky CH, Lull J, Zimmerman D, Doty SB, Aota S, Globus RK. Fibronectin regulates calvarial osteoblast differentiation. J Cell Sci 1996;109:1369-1380.
36. Moursi AM, Globus RK, Damsky CH. Interactions between integrin receptors and fibronectin are required for calvarial osteoblast differentiation in vitro. J Cell Sci 1997;110:2187-2196.
37. Dee KC, Rueger DC, Andersen TT, Bizios R. Conditions which promote mineralization at the bone-implant interface: A model in vitro study. Biomaterials 1996;17:209-215.
38. Siebers MC, ter Brugge PJ, Walboomers XF, Jansen JA. Integrins as linker proteins between osteoblasts and bone replacing materials. A critical review. Biomaterials 2005;26:137-146.
39. Puleo DA, Nanci. A. Understanding and controlling the bone-implant interface. Biomaterials 1999;20:2311-2321.
40. Nanci A, Zalzal S, Gotoh Y, McKee MD. Ultrastructural characterization and immunolocalization of osteopontin in rat calvarial osteoblast primary cultures. Microsc Res Tech 1996;33:214-231.
41. Davies JE. In vitro modeling of the bone/implant interface. Anat Rec 1996;245:426-445.
42. De Oliveira PT, Zalzal SF, Beloti MM, Rosa AL, Nanci A. Enhancement of in vitro osteogenesis on titanium by chemically produced nanotopography. J Biomed Mater Res A 2006; Epub ahead of print. http://dx.doi.Org/10.1002/jbm.a.30955.
43. Bellows CG, Aubin JE, Heersche JNM, Antosz ME. Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations. Calcif Tissue Int 1986;38:143-154.
44. Aubin JE. Advances in the osteoblast lineage. Biochem Cell Biol 1998;76:899-910.
45. Bellows CG, Aubin JE. Determination of numbers of osteoprogenitors present in isolated fetal rat calvaria cells in vitro. Dev Biol 1989;133:8-13.
46. Malaval L, Liu F, Roche P, Aubin JE. Kinetics of osteoprogenitor proliferation and osteoblast differentiation in vitro. J Cell Biochem 1999;74:616-627.
47. Jilka RL, Weinstein RS, Bellido T, Parfitt AM, Manolagas SC. Osteoblast programmed cell death (apoptosis): Modulation by growth factors and cytokines. J Bone Miner Res 1998;13:793-802.
48. Jilka RL, Weinstein RS, Bellido T, Roberson P, Parfitt AM, Manolagas SC. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest 1999;104:439-446.
49. Fokin VM, Potapov OV, Chinaglia CR, Zanotto ED. The effect of pre-existing crystals on the crystallization kinetics of a soda-lime-silica glass. The courtyard phenomenon. J Non-Cryst Solids 1999;258:180-186.
50. 2 glasses. J Non-Cryst Solids 2003;331:240-253.